Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Elixinol Wellness.
RELATED STOCKHEAD STORIES
News
Weed Week: American pot could be worth $60 billion by 2025
News
Weed Week: Oz gets serious with medical marijuana, new clinics rolling out soon
News
Weed Week: US looks at ways to help cannabis players get banking access
News
Weed week: cannabis is about to get scary in Canada
Health & Biotech
The Pot Seat distilled: The 9 key things we know now about Aussie cannabis
Health & Biotech
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Health & Biotech
Feeling chubby? Check out these obesity-blasting ASX stocks
Health & Biotech
Elixinol raises another $50m, bringing its total fundraising to $120m in 18 months
News
Weed Week: Which of you were forced to sell your beloved pot stocks last week?
News
IG Markets looked at almost 1000 pot stocks before deciding to ban 19
Health & Biotech
A third of US CBD companies are ‘about to disappear’ – and that’s great news
News
Weed Week: Will Australia fear to tread where NZ steps with cannabis legalisation?
News
Quarterlies: Elixinol revenue slides as cash burn jumps nearly 290pc
News
Weed Week: Has pot *really* gone from Pineapple Express to luxury status symbol?
News
Women are naturally drawn to medical marijuana, says Elixinol Global MD
Food & Agriculture
Weed Week: How do you compete in the US? Money and Martha Stewart
Food & Agriculture
